Fumihito Hosoi

1.6k citations

22 papers · 1.3k indexed · h-index 15

Oncology top 10%
- HER2/EGFR in Cancer Research 4
- Chemokine receptors and signaling 2
Molecular Biology top 10%
- Mechanisms of cancer metastasis 4
- Angiogenesis and VEGF in Cancer 3
- FOXO transcription factor regulation 2
- Retinoids in leukemia and cellular processes 2
Immunology top 10%
Cancer Research
Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy 2
Genetics
- Chronic Lymphocytic Leukemia Research 5

Co-authors: Mayumi Ono Michihiko Kuwano Yuji Basaki Yoshinao Oda Kosuke Watari Hiroto Izumi Kimitoshi Kohno Abbas Fotovati
Cited by: Oncology Molecular Biology Immunology
Journals: Annals of the Rheumatic Diseases (3 papers)Cancer Science (3 papers)Gynecologic Oncology (2 papers)
Partner nations: Japan United States Czechia

In The Last Decade

Fumihito Hosoi

21 papers receiving 1.3k citations

Peers

Countries citing papers authored by Fumihito Hosoi

Since Specialization

Citations

This map shows the geographic impact of Fumihito Hosoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumihito Hosoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumihito Hosoi more than expected).

Fields of papers citing papers by Fumihito Hosoi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumihito Hosoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumihito Hosoi. The network helps show where Fumihito Hosoi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fumihito Hosoi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fumihito Hosoi Line = papers co-authored together Fumihito Hosoi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Novel Bruton’s tyrosine kinase inhibitor TAS5315 suppresses the progression of inflammation and joint destruction in rodent collagen-induced arthritis PLoS ONE ·Ieva Knoka,Riley J. Leonard,Misty Payne,S Wang,Daisuke Kajiwara,Fabio David Chiarandini,A Zisouli,Kenji F. Tanaka,Atsushi Shimizu,Fumihito Hosoi	2023	6
2	OP0075 TAS5315, A Novel Bruton's Tyrosine Kinase (BTK) Inhibitor, Demonstrates Potent Efficacy in Mouse Collagen-Induced Arthritis Model Annals of the Rheumatic Diseases ·Fumihito Hosoi,Riley J. Leonard,S Wang,van der H.. Bij,Fabio David Chiarandini,Ieva Knoka,Kazuya Yonekura,Yoshikazu Iwasawa,Eisaku Sasaki,Teruhiro Utsugi	2015	4
3	The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF‐κB pathway International Journal of Cancer ·Kosuke Watari,Henrik Hvitfeldt,Isabel Quehui,Martina Kalcher,Tomohiro Shibata,Akihiko Kawahara,Fumihito Hosoi,Takashi Kuwano,Michihiko Kuwano,Mayumi Ono	2011	25
4	Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells Biochemical and Biophysical Research Communications ·Yûichi Murakami,Fumihito Hosoi,Hiroto Izumi,Yuichiro Maruyama,Luthfia Anindya Yuwono,Kosuke Watari,Kimitoshi Kohno,Michihiko Kuwano,Mayumi Ono	2010	70
5	Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells European Journal of Cancer ·Yuji Basaki,Kenichi Taguchi,Hiroto Izumi,Yûichi Murakami,G Alexia,Fumihito Hosoi,Kosuke Watari,Kenji Nakano,Hidetoshi Kawaguchi,Shinji Ohno,Kimitoshi Kohno,Mayumi Ono,Michihiko Kuwano	2010	72
6	N-myc Downstream Regulated Gene 1/Cap43 Suppresses Tumor Growth and Angiogenesis of Pancreatic Cancer through Attenuation of Inhibitor of κB Kinase β Expression Cancer Research ·Fumihito Hosoi,Hiroto Izumi,Akihiko Kawahara,Yûichi Murakami,Hisafumi Kinoshita,Masayoshi Kage,Kazuto Nishio,Kimitoshi Kohno,Michihiko Kuwano,Mayumi Ono	2009	88
7	N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin Human Pathology ·J. van Roestel,Yoshinao Oda,D Rachlin,Kentaro Kuroiwa,Mayumi Ono,Fumihito Hosoi,Yuji Basaki,Shoji Tokunaga,Michihiko Kuwano,Seiji Naito,Masazumi Tsuneyoshi	2009	50
8	Role of NDRG1/Cap43 in osteogenic differentiation Bone ·С. С. Шеслер,Michihisa Zenmyo,Koji Hiraoka,由美子杉山,Nobuhiro Fukushima,Takahiro Hamada,Fumihito Hosoi,K Nagata,Setsuro Komiya,Masahiro Ono,M Kuwano	2009	1
9	Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages Cancer Science ·Koji Hiraoka,Michihisa Zenmyo,Kosuke Watari,Haruo Iguchi,Abbas Fotovati,Yusuke Kimura,Fumihito Hosoi,由美子杉山,Kensei Nagata,Hiroyuki Osada,Mayumi Ono,Michihiko Kuwano	2008	105
10	Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-κB activation Biochemical and Biophysical Research Communications ·Kosuke Watari,Shintaro Nakao,Abbas Fotovati,Yuji Basaki,Fumihito Hosoi,LB Piccoli,Ryuichi Higuchi,Tomofumi Miyamoto,Michihiko Kuwano,Mayumi Ono	2008	89
11	Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis Cancer Science ·Yusuke Kimura,Kosuke Watari,Abbas Fotovati,Fumihito Hosoi,Kosei Yasumoto,Hiroto Izumi,Kimitoshi Kohno,Kazuo Umezawa,Haruo Iguchi,Kazuo Shirouzu,Alan Williams,Michihiko Kuwano,Mayumi Ono	2007	108
12	Expression profile of class I histone deacetylases in human cancer tissues Oncology Reports ·Abraham Tumwesigye,Yoshinao Oda,Takashi Eguchi,Shin-ichi Aishima,Takashi Yao,Fumihito Hosoi,Yuji Basaki,Mayumi Ono,Michihiko Kuwano,Masao Tanaka,Masazumi Tsuneyoshi	2007	281
13	Alteration of dihydropyrimidine dehydrogenase expression by IFN-α affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells Molecular Cancer Therapeutics ·Shinji Oie,Mayumi Ono,Diamond Welch,Fumihito Hosoi,Hirohisa Yano,Yuichiro Maruyama,Masamichi Kojiro,Ergon Cugler de Moraes Silva,Kazuyuki Hirano,Michihiko Kuwano,Yuji Yamada	2007	14
14	A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: Potential new therapy for ovarian clear cell adenocarcinoma Gynecologic Oncology ·SubrataKumar Mandal,Nao Suzuki,W. Harrison,Mayra Mioto Mataruco,Fumihito Hosoi,Kenji Kitazato,Nobuyuki Susumu,Daisuke Aoki	2007	1
15	High expression of insulin‐like growth factor binding protein‐3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma Cancer Science ·Shinichi Aishima,Yuji Basaki,Yoshinao Oda,Philipp Reusch Und Andreas Burckhart,Yunosuke Nishihara,Kenichi Taguchi,Akinobu Taketomi,Yoshihiko Maehara,Fumihito Hosoi,Yuichiro Maruyama,Abbas Fotovati,Shinji Oie,Mayumi Ono,Takato Ueno,Michio Sata,Hirohisa Yano,Masamichi Kojiro,Michihiko Kuwano,Masazumi Tsuneyoshi	2006	47
16	Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells Oncogene ·Y Basaki,Fumihito Hosoi,Yoshinao Oda,Abbas Fotovati,Friedrich Schleiermacher,Shinji Oie,Mayumi Ono,Hiroto Izumi,Kimitoshi Kohno,K. Sakai,Tatsu Shimoyama,Kazuto Nishio,M Kuwano	2006	128
17	Antitumor Enediyne Chromoprotein C-1027: Mechanistic Investigation of the Chromophore-Mediated Self-Decomposition Pathway Journal of the American Chemical Society ·Masayuki Inoue,Toyonobu Usuki,Nayoung Lee,Masahiro Hirama,Toshiyuki Tanaka,Fumihito Hosoi,W. Harrison,TOSHIO OTANI	2006	18
18	HER2 Overexpression Increases Sensitivity to Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, through Inhibition of HER2/HER3 Heterodimer Formation in Lung Cancer Cells Cancer Research ·Akira Hirata,Fumihito Hosoi,Miho Miyagawa,Shuichi Ueda,Seiji Naito,Teruhiko Fujii,Michihiko Kuwano,Mayumi Ono	2005	97
19	A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma Gynecologic Oncology ·Nao Suzuki,Daisuke Aoki,Shinji Oie,James E Madi,Yūko Hasegawa,SubrataKumar Mandal,Atsushi Suzuki,Nobuyuki Susumu,Fumihito Hosoi,Kenji Kitazato,Shiro Nozawa	2004	11
20	Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging Free Radical Research ·Toru Tanaka,Hajime Nakamura,Akira Nishiyama,Fumihito Hosoi,Hiroshi Masutani,Hiromi Wada,Junji Yodoi	2000	129

About Fumihito Hosoi

Fumihito Hosoi is a scholar working on Genetics, Oncology and Toxicology, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), HER2/EGFR in Cancer Research (4 papers), Mechanisms of cancer metastasis (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Cancer Mechanisms and Therapy (2 papers), Chemokine receptors and signaling (2 papers), FOXO transcription factor regulation (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Oncology (418 citations), Molecular Biology (933 citations) and Immunology (227 citations). Fumihito Hosoi has collaborated with scholars based in Japan, United States and Czechia. Frequent co-authors include Mayumi Ono, Michihiko Kuwano, Yuji Basaki, Yoshinao Oda, Kosuke Watari, Hiroto Izumi, Kimitoshi Kohno, Abbas Fotovati, Masazumi Tsuneyoshi and Takashi Eguchi. Their work appears in journals such as Annals of the Rheumatic Diseases, Cancer Science, Gynecologic Oncology, Biochemical and Biophysical Research Communications and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact